David A Reardon · researcher · YYNN

David A Reardon

? TBD

researcher

Ratings
0

Nobody has rated this yet. Be the first!

Works
1

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

scientific article

Lists
0

Instance of

Occupation

Wikidata